Wells Fargo & Company »

Beam Therapeutics shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.0M 37k 27.22
2023-09-30 $2.4M 98k 24.08
2023-06-30 $2.7M 86k 31.93
2022-12-31 $648k 17k 39.11
2022-09-30 $1.0M 21k 47.66
2022-06-30 $2.9M 75k 38.33
2022-03-31 $5.1M 90k 57.32
2021-12-31 $5.2M 66k 78.95
2021-09-30 $4.8M 55k 86.96
2021-06-30 $7.5M 58k 128.81
2021-03-31 $3.7M 46k 80.05
2020-12-31 $3.1M 38k 81.63
2020-09-30 $814k 33k 24.61
2020-06-30 $407k 15k 27.99
2020-03-31 $142k 7.9k 17.97